These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7609670)

  • 1. Aluminum binds to the hyperphosphorylated tau in Alzheimer's disease: a hypothesis.
    Zatta PF
    Med Hypotheses; 1995 Mar; 44(3):169-72. PubMed ID: 7609670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease.
    Shin RW; Kruck TP; Murayama H; Kitamoto T
    Brain Res; 2003 Jan; 961(1):139-46. PubMed ID: 12535786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
    Walton JR
    J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for participation of aluminum in neurofibrillary tangle formation and growth in Alzheimer's disease.
    Walton JR
    J Alzheimers Dis; 2010; 22(1):65-72. PubMed ID: 20847423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients.
    Harrington CR; Wischik CM; McArthur FK; Taylor GA; Edwardson JA; Candy JM
    Lancet; 1994 Apr; 343(8904):993-7. PubMed ID: 7909090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of tau in the development of Alzheimer's disease].
    Takashima A
    Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein studies try to puzzle out Alzheimer's tangles.
    Roush W
    Science; 1995 Feb; 267(5199):793-4. PubMed ID: 7846523
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurofibrillary pathology and aluminum in Alzheimer's disease.
    Shin RW; Lee VM; Trojanowski JQ
    Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
    Huang HC; Jiang ZF
    J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
    Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
    Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of tau phosphorylation in Alzheimer's disease.
    Lee VM
    Ann N Y Acad Sci; 1996 Jan; 777():107-13. PubMed ID: 8624072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperphosphorylation of human TAU by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease.
    Blanchard BJ; devi Raghunandan R; Roder HM; Ingram VM
    Biochem Biophys Res Commun; 1994 Apr; 200(1):187-94. PubMed ID: 8166686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites.
    Su JH; Cummings BJ; Cotman CW
    Neuroreport; 1994 Nov; 5(17):2358-62. PubMed ID: 7533559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-922 promotes tau phosphorylation by downregulating ubiquitin carboxy-terminal hydrolase L1 (UCHL1) expression in the pathogenesis of Alzheimer's disease.
    Zhao ZB; Wu L; Xiong R; Wang LL; Zhang B; Wang C; Li H; Liang L; Chen SD
    Neuroscience; 2014 Sep; 275():232-7. PubMed ID: 24950120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity.
    Alonso Adel C; Li B; Grundke-Iqbal I; Iqbal K
    Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8864-9. PubMed ID: 16735465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease.
    Guo JP; Arai T; Miklossy J; McGeer PL
    Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1953-8. PubMed ID: 16446437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer disease hyperphosphorylated tau aggregates hydrophobically.
    Ruben GC; Ciardelli TL; Grundke-Iqbal I; Iqbal K
    Synapse; 1997 Nov; 27(3):208-29. PubMed ID: 9329157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease.
    Lau DH; Hogseth M; Phillips EC; O'Neill MJ; Pooler AM; Noble W; Hanger DP
    Acta Neuropathol Commun; 2016 May; 4(1):49. PubMed ID: 27193083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer's disease pathology.
    Arendt T; Stieler J; Holzer M
    J Neural Transm (Vienna); 2015 Apr; 122(4):531-9. PubMed ID: 25480630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.